The National Institute on Drug Abuse (NIDA) has made available a new tool designed to screen adult primary care patients for substance misuse and substance use disorder. Dr. Robert Schwartz served as Lead Investigator of a NIDA Clinical Trials Network study of the Tobacco, Alcohol, Prescription medication, and other Substance use (TAPS) Tool. The TAPS […]
FRI is proud to announce that Dr. Jan Gryczynski received the Most Reviewed Articles award from the Journal of Addiction Medicine for peer reviewing six papers for the Journal in 2017. Click here to see article.
Dr. Robert Schwartz chaired the development of the Substance Abuse and Mental Health Services Administration’s (SAMHSA) recently released Treatment Improvement Protocol (TIP) 63 entitled Medications for Opioid Use Disorder. The resources in this publication can help healthcare and addiction treatment providers, policymakers, patients, and families address the opioid crisis. This up-to-date publication provides: an introduction […]
Dr. Robert Schwartz’s team demonstrated the sensitivity and specificity of the BSTAD in primary care settings. The National Institute on Drug Abuse has made this tool available at: https://www.drugabuse.gov/adolescent-substance-use-screening-tools.
FRI is pleased to announce that Dr. Michael Gordon, along with Co-Investigators Drs. Frank Vocci, Marc Fishman, and Faye Taxman have received a grant award from the National Institute on Drug Abuse entitled “Buprenorphine for probationers and parolees: Bridging the gap into treatment.” This five-year study is a two-group randomized controlled trial in which 320 […]
Wanda Cross began working for Friends Research Institute (FRI) in 1964 at the young age of 19. She continued to work with FRI for 54 years, which is quite an amazing achievement these days. During her tenure with FRI, Wanda initially worked in the accounting department as a bookkeeper and over the years, after gaining […]
The Pew Charitable Trusts released an October 2017 report entitled, “Prison Health Care: Costs and Quality—How and why states strive for high-performing systems.” Drs. Michael Gordon and Robert Schwartz had four of their study journal publications cited in the report: (1) Extended-Release Naltrexone to Prevent Opioid Relapse in Criminal Justice Offenders, (2) A Randomized Clinical […]
Dr. Thomas Blue was awarded a Junior Investigator scholarship by the Academic Consortium on Criminal Justice Health to attend their conference held in Houston, Texas in March of 2018. The award provided support for travel expenses and covered the costs of registration and lodging. Dr. Blue planned to present preliminary findings gathered from a long-term […]
FRI is pleased to announce that Dr. Thomas Blue has accepted a position as an Assistant Research Scientist at FRI. Dr. Blue’s research focuses on the treatment of substance use disorders and health disparities in criminal justice populations (prisoners, parolees, and probationers). While completing his degree at Texas Christian University, he worked on a NIDA […]
FRI is pleased to announce that Dr. Mary Mitchell has accepted a position as an Assistant Research Scientist at FRI. Dr. Mitchell is a public health research scientist with a focus on the role of caregivers of people living with HIV/AIDS (PLHIV) and the ways in which caregivers can influence the health behaviors of their […]
